Zypitamag patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8829186 MEDICURE Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof
Jan, 2031

(7 years from now)

Zypitamag is owned by Medicure.

Zypitamag contains Pitavastatin Magnesium.

Zypitamag has a total of 1 drug patent out of which 0 drug patents have expired.

Zypitamag was authorised for market use on 14 July, 2017.

Zypitamag is available in tablet;oral dosage forms.

The generics of Zypitamag are possible to be released after 19 January, 2031.

Drugs and Companies using PITAVASTATIN MAGNESIUM ingredient

Market Authorisation Date: 14 July, 2017

Treatment: NA


More Information on Dosage

ZYPITAMAG family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic